New d-configured cateslytin peptide
AssigneesUniversite De Strasbourg, Institut National de la Sante et de la Recherche Medicale
InventorsCéline MARBAN, Marie-Hélène METZ-BOUTIGUE, Philippe LAVALLE, Pierre SCHAAF, Youssef HAIKEL
Life of this patent
Estimating the term…
Abstract
The present invention relates to a cateslytin peptide having an amino acid sequence consisting or consisting essentially of the sequence of SEQ ID NO: 1, wherein at least 80%, preferably at least 90%, of the amino acids residues of said cateslytin are D-configured. The invention also relates to the use of said cateslytin peptide as a drug, especially in the treatment of an infection in a patient in needs thereof.
Claims16
1-15. (canceled)
A cateslytin peptide having an amino acid sequence consisting essentially in the sequence of SEQ ID NO:
- 1, wherein at least 60% of the amino acids residues of said cateslytin are D-configured.
Dependencies are inferred from the claim text.